Nanobiotix
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Nanobiotix and buy or sell other stocks, ETFs, and their options commission-free!About NBTX
Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells.
CEOLaurent Lévy
CEOLaurent Lévy
Employees97
Employees97
HeadquartersParis, Ile-de-France
HeadquartersParis, Ile-de-France
Founded2003
Founded2003
Employees97
Employees97
NBTX Key Statistics
Market cap1.69B
Market cap1.69B
Price-Earnings ratio-57.80
Price-Earnings ratio-57.80
Dividend yield—
Dividend yield—
Average volume133.47K
Average volume133.47K
High today$35.60
High today$35.60
Low today$33.01
Low today$33.01
Open price$34.89
Open price$34.89
Volume148.75K
Volume148.75K
52 Week high$57.14
52 Week high$57.14
52 Week low$10.58
52 Week low$10.58
NBTX News
Investing.com 5d
Guggenheim initiates Nanobiotix stock rating at Buy on cancer drug - Investing.com...
TipRanks 5d
Nanobiotix assumed with a Buy at GuggenheimGuggenheim assumed coverage of Nanobiotix (NBTX) with a Buy rating and $64 price target. The firm’s investment thesis is centered on the company’s first-in-clas...
TipRanks 7d
Nanobiotix Lung Cancer Trial Shows Strong Safety and Control at Lower Radiation DosesNanobiotix ( (FR:NANO) ) has provided an update. Nanobiotix reported updated Phase 1 data from a University of Texas MD Anderson Cancer Center–sponsored trial...
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.